Publicaciones en colaboración con investigadores/as de University College London (56)

2024

  1. Common pitfalls, and how to avoid them, in child and adolescent psychopharmacology: Part I

    Journal of Psychopharmacology, Vol. 38, Núm. 4, pp. 311-317

  2. Common pitfalls, and how to avoid them, in child and adolescent psychopharmacology: Part II

    Journal of Psychopharmacology, Vol. 38, Núm. 4, pp. 318-323

  3. Prevalence and Correlates of the Concurrence of Autism Spectrum Disorder and Obsessive Compulsive Disorder in Children and Adolescents: A Systematic Review and Meta-Analysis

    Brain Sciences, Vol. 14, Núm. 4

  4. Psychopharmacology in children and adolescents: unmet needs and opportunities

    The Lancet Psychiatry, Vol. 11, Núm. 2, pp. 143-154

  5. Running in the FAMILY: understanding and predicting the intergenerational transmission of mental illness

    European Child and Adolescent Psychiatry

  6. Self-reported suicidal ideation among individuals with first episode psychosis and healthy controls: Findings from the international multicentre EU-GEI study

    Schizophrenia Research, Vol. 270, pp. 339-348

  7. Sexual dimorphism in the enamel-dentine junction (EDJ) of permanent canines of European modern humans

    American Journal of Biological Anthropology, Vol. 184, Núm. 2

  8. The Role of Social Deprivation and Cannabis Use in Explaining Variation in the Incidence of Psychotic Disorders: Findings From the EU-GEI Study

    Schizophrenia Bulletin, Vol. 50, Núm. 5, pp. 1039-1049

  9. The lived experience of mental disorders in adolescents: a bottom-up review co-designed, co-conducted and co-written by experts by experience and academics

    World Psychiatry, Vol. 23, Núm. 2, pp. 191-208

  10. Trace amine-associated receptor 1 (TAAR1) agonism for psychosis: a living systematic review and meta-analysis of human and non-human data

    Wellcome Open Research, Vol. 9

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Cannabis use as a potential mediator between childhood adversity and first-episode psychosis: Results from the EU-GEI case-control study

    Psychological Medicine, Vol. 53, Núm. 15, pp. 7375-7384

  3. Common practical questions – and answers – at the British Association for Psychopharmacology child and adolescent psychopharmacology course

    Journal of Psychopharmacology, Vol. 37, Núm. 2, pp. 119-134

  4. Development and Validation of Predictive Model for a Diagnosis of First Episode Psychosis Using the Multinational EU-GEI Case-control Study and Modern Statistical Learning Methods

    Schizophrenia Bulletin Open, Vol. 4, Núm. 1

  5. Differences in Patterns of Stimulant Use and Their Impact on First-Episode Psychosis Incidence: An Analysis of the EUGEI Study

    Schizophrenia Bulletin, Vol. 49, Núm. 5, pp. 1269-1280

  6. Exploring the mediation of DNA methylation across the epigenome between childhood adversity and First Episode of Psychosis—findings from the EU-GEI study

    Molecular Psychiatry, Vol. 28, Núm. 5, pp. 2095-2106

  7. First-Episode Psychosis Patients Who Deteriorated in the Premorbid Period Do Not Have Higher Polygenic Risk Scores Than Others: A Cluster Analysis of EU-GEI Data

    Schizophrenia bulletin, Vol. 49, Núm. 1, pp. 218-227

  8. New living evidence resource of human and non-human studies for early intervention and research prioritisation in anxiety, depression and psychosis

    BMJ mental health, Vol. 26, Núm. 1

  9. Schizophrenia risk conferred by rare protein-truncating variants is conserved across diverse human populations

    Nature genetics, Vol. 55, Núm. 3, pp. 369-376

  10. Synergistic effects of childhood adversity and polygenic risk in first-episode psychosis: The EU-GEI study

    Psychological Medicine, Vol. 53, Núm. 5, pp. 1970-1978